Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jamie Buryanek
A Novel Immunomodulatory and Molecularly Targeted Strategy for Refractory Hodgkin’s Lymphoma
Oncotarget
Oncology
Related publications
Treatment of Relapse and Refractory Hodgkin Lymphoma
Oncogematologiya
Oncology
Hematology
Treatment of Relapsed and Refractory Hodgkin Lymphoma – Recommendations of the Czech Hodgkin Lymphoma Study Group
Klinicka Onkologie
Oncology
CD30-targeted Oncolytic Viruses as Novel Therapeutic Approach Against Classical Hodgkin Lymphoma
Oncotarget
Oncology
Management of Patients With Non-Hodgkin’s Lymphoma: Focus on Adoptive T-Cell Therapy
ImmunoTargets and Therapy
Allergy
Immunology
Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Experience in Turkey
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Hodgkin´s Lymphoma and Autoimmunity: Is There a Relationship?
Acta Medica Portuguesa
Medicine
Rapidly Progressing Refractory Hodgkin Lymphoma: A Case Report and a Possible Explanation
Case Reports in Medicine
Medicine
Tandem Autologous-Haploidentical Transplantation Is a Feasible and Effective Program for Refractory Hodgkin Lymphoma
Bone Marrow Transplantation
Transplantation
Hematology
Acute Pancreatitis Following Brentuximab Vedotin Therapy for Refractory Hodgkin Lymphoma: A Case Report
Drugs in R and D
Pharmacology